Skip to main content
logo
PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.040
-0.090 (-4.23%)
Aug 7, 2026, 4:10 PM AEST

PYC Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
2,006755560191207493
Market Cap Growth
164.61%34.90%192.66%-7.47%-58.06%46.25%
Enterprise Value
1,887708536175165438
Last Close Price
2.041.261.170.540.621.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
97.5932.1525.3812.1012.89160.37
PB Ratio
13.624.446.916.735.149.14
P/TBV Ratio
13.994.567.338.145.9210.19

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
91.7730.1224.2911.1010.26142.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.010.010.010.010.020.01
Net Debt / Equity Ratio
-0.81-0.89-0.81-0.54-0.70-0.94
Net Debt / EBITDA Ratio
2.332.881.730.672.062.77
Net Debt / FCF Ratio
1.812.891.690.611.274.10
Asset Turnover
0.180.170.340.380.310.07
Quick Ratio
13.9214.389.323.798.9315.68
Current Ratio
13.9614.419.403.798.9515.71
Return on Equity (ROE)
-47.55%-40.64%-69.61%-68.05%-30.37%-44.29%
Return on Assets (ROA)
-28.68%-24.42%-37.83%-35.49%-17.29%-26.20%
Return on Capital Employed (ROCE)
-35.20%-31.40%-47.30%-81.50%-34.90%-34.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-2.37%-6.66%-6.74%-11.91%-6.71%-3.60%
FCF Yield
-3.30%-6.96%-6.95%-13.02%-10.72%-2.51%
Buyback Yield / Dilution
-27.58%-27.16%-22.59%-0.93%-2.89%-12.58%